Company Overview and News

 
Texhong Textile: Valuation Discount To Peers Should Narrow On Execution Of Vertical Integration Plans

2018-02-14 seekingalpha
As an upstream textile supplier, Texhong Textile is trading at a discount to listed peers operating further downstream. Valuation discount is likely to narrow, as the company integrates downstream.

 
Bloomberg Billionaires Index - Zhang Shiping

2017-11-02 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

 
China Metal Magnate Faces Reality Under Xi - Bloomberg

2017-11-02 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

 
Debt distress in Shandong province illustrates risks of interlocked credit guarantees

2017-04-09 scmp
A financing crisis that broke out among a group of private firms in east China’s Shandong province – involving several mainland and Hong Kong listed companies – appears to have calmed, as the company at the centre of the quarrel repaid its outstanding debt and interest on Friday.

 
Weiqiao Textile Announces its 2016 Interim Results

2016-08-22 accesswire
- Revenue was approximately RMB4,380 million, a year-on-year decrease of approximately 9.9% - Gross profit was approximately RMB74 million, a year-on-year decrease of approximately 63.9% - Net Profit attributable to owners of the parent was approximately RMB343 million, a year-on-year increase of approximately 9.2% - Earnings per share were RMB0.29, a year-on-year increase of approximately 11.5%

 
Weiqiao Textile Announces its 2015 Annual Results

2016-03-21 accesswire
HONG KONG, CHINA / ACCESSWIRE / March 21, 2016 / Weiqiao Textile Company Limited ("the Company" or "Weiqiao Textile") and its subsidiaries, collectively the "Group") (HKEX: 2698), the largest cotton textile producer in China, announced its annual results for the year ended December 31, 2015 (the "Review Period" or the "Period").

 
World Denim Fabric Market (US, Europe, China, Japan) 2016-2021 Forecasts

2016-02-05 prnewswire
PUNE, India, February 5, 2016 /PRNewswire/ -- DeepResearchReports.com adds 2016 Market Research Report on Global...

Related Articles

SGMO: Sangamo BioSciences and Research Report

2018-05-19 - Asif

OVERVIEW Sangamo BioSciences is a clinical stage biotechnology company focused on translating ground-breaking science into genomic therapies that transform patients’ lives using its industry-leading platform technologies in genome editing, gene therapy, gene regulation and cell therapy. Sangamo BioSciences is a leader in the research and development of zinc finger proteins, or ZFPs, a naturally occurring class of proteins found in humans. Sangamo BioSciences has used its knowledge and expertise to develop a proprietary technology platform in both genome editing and gene regulation. ZFPs can be engineered to make zinc finger nucleases, or ZFNs, proteins that can be used to specifically modify DNA sequences by adding or knocking out specific genes, or genome editing, and ZFP transcription factors or ZFP TFs, proteins that can be used to increase or decrease gene expression, or gene regulation. In the process of developing this platform, Sangamo BioSciences has accrued signific...

HMNY: Helios and Matheson Analytics and Research Report

2018-05-19 - Asif

Business Overview The company provide high quality information technology, or IT, services and solutions including a range of technology platforms focusing on big data, business intelligence, and consumer-centric technology. More recently, to provide greater value to stockholders, the Company has sought to expand its business primarily through acquisitions that leverage its capabilities and expertise. As of March 31, 2018, the Company owned 81.2%, and as of the date of this report the Company owns 91.8%, of the outstanding shares of MoviePass (excluding outstanding MoviePass options and warrants). MoviePass is the premiere movie theater subscription service in the United States which provides its subscribers the ability to view up to one new movie title per day for one monthly subscription price. The company's more than 2 million subscribers have access to see films in over 91% of U.S movie theaters. By the end of April 2018, the company implemented certain measures ...

BSTG: Biostage Analysis and Research Report

2018-05-17 - Asif

Overview Biostage is a biotechnology company developing bioengineered organ implants based on its novel CellframeTM technology. The company's Cellframe technology is comprised of a biocompatible scaffold that is seeded with the recipient’s own stem cells. This technology is being developed to treat life-threatening conditions of the esophagus, trachea or bronchus with the objective of dramatically improving the treatment paradigm for those patients. The company believe that its Cellframe technology will provide surgeons with new ways to address damage to the esophagus, bronchus, and trachea due to congenital abnormalities, cancer, infection or trauma. Products being developed based on its Cellframe technology for those indications are called CellspanTM products. The company announced favorable preliminary pre-clinical results of large-animal studies for the esophagus, trachea and bronchus in November 2015. Since then, the Cellspan esophageal implant product candidates hav...